Denosumab osteoporosis drug

Denosumab osteoporosis drug

C028/4457 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.1MB

Downloadable file size: 6.8MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Denosumab osteoporosis drug. Syringe containing the monoclonal antibody drug denosumab, marketed under the name Prolia. Denosumab is used to treat osteoporosis, treatment-induced bone loss, metastatic bone cancer, and giant cell tumour of bone.

Release details: Model release not required. Property release not required.

Keywords: antibodies, bone disease, bone loss, brand, branded, close-up, condition, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, denosumab, detail, device, disease, diseases, disorder, drug, drugs, equipment, giant cell tumour, healthcare, igg, immunoglobulin, injection, medical, medicine, metastases, metastatic bone cancer, monoclonal antibody, no-one, nobody, osteoporosis, pharmaceutical, pharmaceutics, pharmacological, pharmacology, prescribed, prescription, product, prolia, still life, still-life, syringe, treatment, treatment-induced, tumor, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.